Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Status:
Completed
Trial end date:
2016-05-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy and safety of isavuconazole in the
treatment of renally impaired participants with invasive fungal infections caused by
Aspergillus and participants with invasive fungal disease caused by rare fungi.